Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP804249.RA1bzW5M9C1CHDJToBEjQJ6xv1eB2nYuwRoPqIaDr5pCI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP804249.RA1bzW5M9C1CHDJToBEjQJ6xv1eB2nYuwRoPqIaDr5pCI130_assertion type Assertion NP804249.RA1bzW5M9C1CHDJToBEjQJ6xv1eB2nYuwRoPqIaDr5pCI130_head.
- NP804249.RA1bzW5M9C1CHDJToBEjQJ6xv1eB2nYuwRoPqIaDr5pCI130_assertion description "[Hypodense activated eosinophils have been described in various diseases such as parasitic or allergic diseases, hypereosinophilic syndrome (HES) associated in some cases to myeloproliferative markers, and more recently described in patients undergoing recombinant IL2 treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804249.RA1bzW5M9C1CHDJToBEjQJ6xv1eB2nYuwRoPqIaDr5pCI130_provenance.
- NP804249.RA1bzW5M9C1CHDJToBEjQJ6xv1eB2nYuwRoPqIaDr5pCI130_assertion evidence source_evidence_literature NP804249.RA1bzW5M9C1CHDJToBEjQJ6xv1eB2nYuwRoPqIaDr5pCI130_provenance.
- NP804249.RA1bzW5M9C1CHDJToBEjQJ6xv1eB2nYuwRoPqIaDr5pCI130_assertion SIO_000772 2037012 NP804249.RA1bzW5M9C1CHDJToBEjQJ6xv1eB2nYuwRoPqIaDr5pCI130_provenance.
- NP804249.RA1bzW5M9C1CHDJToBEjQJ6xv1eB2nYuwRoPqIaDr5pCI130_assertion wasDerivedFrom befree-2016 NP804249.RA1bzW5M9C1CHDJToBEjQJ6xv1eB2nYuwRoPqIaDr5pCI130_provenance.
- NP804249.RA1bzW5M9C1CHDJToBEjQJ6xv1eB2nYuwRoPqIaDr5pCI130_assertion wasGeneratedBy ECO_0000203 NP804249.RA1bzW5M9C1CHDJToBEjQJ6xv1eB2nYuwRoPqIaDr5pCI130_provenance.